Spain: Asabys targets biotech and healthtech in Southern Europe with new fund

Asabys, a Barcelona-headquartered specialized healthcare sector VC, has launched a new €200m (US$201m) fund (SAHII 2) that will invest in biotech and healthtech. The fund’s first closing is expected by the end of this year, backed by commitments from institutional and private investors such as Banc Sabadell and the Alantra Investment Pool (Alantra & Mutua)….

You must be a HMI Subscriber to view this content.

Subscribe Now »